Transition Therapeutics Inc (NASDAQ:TTHI)

6.82
Delayed Data
As of Mar 03
 -0.09 / -1.30%
Today’s Change
4.36
Today|||52-Week Range
8.22
-0.25%
Year-to-Date
No recent news for Transition Therapeutics Inc.

Today’s Trading

Previous close6.91
Today’s open6.90
Day’s range6.75 - 7.00
Volume41,748
Average volume (3 months)13,740
Market cap$244.0M
Dividend yield--
Data as of 3:59pm ET, 03/03/2015

Growth & Valuation

Earnings growth (last year)-74,855.56%
Earnings growth (this year)-60.76%
Earnings growth (next 5 years)--
Revenue growth (last year)-100.00%
P/E ratio--
Price/Sales--
Price/Book4.40

Competitors

 Today’s
change
Today’s
% change
CALACalithera Bioscience...-0.25-1.82%
QTNTQuotient Ltd+0.12+0.71%
VCYTVeracyte Inc-0.25-2.82%
OXFDOxford Immunotec Glo...-0.26-1.80%
Data as of 3:59pm ET, 03/03/2015

Financials

Next reporting dateMay 12, 2015
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$0.00
Annual profit (last year)-$20.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Tony F. Cruz
Chief Operating Officer
Carl Damiani
Corporate headquarters
Toronto, Ontario

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account